Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Mary E. Krause, PhD

Director, Formulation Development
BMS
New Brunswick, New Jersey

Mary E. Krause, Ph.D., is Director of Formulation Development in the Sterile Drug Product Development Department of Bristol Myers Squibb in New Brunswick, NJ. In this role, Mary leads a group of formulation scientists and supports formulation and process development of biologic drug products. She has led product teams in developing both monoclonal antibodies and novel protein-based modalities, such as antibody drug conjugates, bispecific antibodies, and fusion proteins.Prior to joining BMS in 2014, Mary earned her B.S. and M.S. in Chemistry from Missouri State University and Ph.D. in Chemistry from the University of Kansas, with subsequent post-doctoral training in pharmaceutical chemistry at the University of Kansas as a PhRMA Foundation Post-Doctoral Fellow. Mary's current research interests include formulation and process development of biologic drug products, with emphasis on antibody drug conjugates, metal-catalyzed oxidation, and the effects of process and interfacial stress on long-term stability. Mary is also passionate about mentoring women in STEM; she sits on the global leadership team of the Bristol Myers Squibb Network of Women and serves as STEM chair for this organization.

Disclosure information not submitted.

Presentation(s):